CrossRef Forward Linking Search Results
This Article:
Yoshiaki Nishimura, Tatsuhiko Igarashi, Nancy L. Haigwood, Reza Sadjadpour, Olivia K. Donau, Charles Buckler, Ron J. Plishka,
Alicia Buckler-White, and Malcolm A. Martin
Transfer of neutralizing IgG to macaques 6 h but not 24 h after SHIV infection confers sterilizing protection: Implications for HIV-1 vaccine development
PNAS 2003 100: 15131-15136.
Transfer of neutralizing IgG to macaques 6 h but not 24 h after SHIV infection confers sterilizing protection: Implications for HIV-1 vaccine development
PNAS 2003 100: 15131-15136.
has been cited by the following articles in journals that are participating in CrossRef's forward linking service: |
||
 |
 |
Of mice and monkeys: new advances in animal models to study HIV-1 therapy and prophylaxis Zandrea Ambrose and Vineet N KewalRamani Future HIV Therapy (2008) 2: 363 Link to Article |
|
||
|
||
|
||
|
|
Anti-HIV adaptive immunity: determinants for viral persistence Hiroyuki Yamamoto and Tetsuro Matano Reviews in Medical Virology (2008) 18: 293 Link to Article |
|
||
|
||
|
||
|
|
Species barrier of HIV‐1 and its jumping by virus engineering Masako Nomaguchi, Naoya Doi, Kazuya Kamada, and Akio Adachi Reviews in Medical Virology (2008) 18: 261 Link to Article |
|
||
|
||
|
||
|
|
HIV-1 rational vaccine design: molecular details of b12?gp120 complex structure Sanjay K Phogat, Stephen M Kaminsky, and Wayne C Koff Expert Review of Vaccines (2007) 6: 319 Link to Article |
|
||
|
||
|
||
|
|
Non-neutralizing antibodies and vaccine-induced protection against HIV Ruth H Florese and Marjorie Robert-Guroff Future HIV Therapy (2007) 1: 259 Link to Article |
|
||
|
||
|
||
|
|
Inhibition of HIV-1 entry by antibodies: potential viral and cellular targets S. Phogat, R. T. Wyatt, and G. B. Karlsson Hedestam Journal of Internal Medicine (2007) 262: 26 Link to Article |
|
||
|
||
|
||
|
|
Virological and immunological bases for HIV-1 vaccine design Hiroyuki YAMAMOTO and Tetsuro MATANO Uirusu (2007) 57: 133 Link to Article |
|
||
|
||
|
||
|
|
Building collaborative networks for HIV/AIDS vaccine development: the AVIP experience Flavia Ferrantelli, Stefano Buttò, Aurelio Cafaro, Britta Wahren, and Barbara Ensoli Springer Seminars in Immunopathology (2006) 28: 289 Link to Article |
|
||
|
||
|
||
|
|
Infection with a molecularly cloned SIVsm virus elicits high titer homologous neutralizing antibodies with heterologous neutralizing
activity M. Mahalanabis, V.M. Hirsch, and N.L. Haigwood Journal of Medical Primatology (2005) 34: 253 Link to Article |
|
||
|
||
|
||
|
|
Annulling a dangerous liaison: vaccination strategies against AIDS and tuberculosis Stefan H E Kaufmann and Andrew J McMichael Nature Medicine (2005) 11: S33 Link to Article |
|
||
|
||
|
||
|
|
Neutralizing antibody responses to HIV: role in protective immunity and challenges for vaccine design Indresh K Srivastava, Jeffrey B Ulmer, and Susan W Barnett Expert Review of Vaccines (2004) 3: S33 Link to Article |
|
||
|
||
|
||
|
|
A call for replicating vector prime-protein boost strategies in HIV vaccine design Nina V Malkevitch and Marjorie Robert-Guroff Expert Review of Vaccines (2004) 3: S105 Link to Article |
|
||
|
||
|
||
Most
-
Read
- Prevention of cardiovascular and renal pathology of aging by the advanced glycation inhibitor aminoguanidine
- Biomimetic tissue-engineered anterior cruciate ligament replacement
- Long-term evolution of transposable elements
- From the Cover: Nanoparticle-mediated drug delivery to tumor vasculature suppresses metastasis
- The mechanism of micro-RNA-mediated translation repression is determined by the promoter of the target gene
-
Cited
- DNA Sequencing with Chain-Terminating Inhibitors
- Electrophoretic Transfer of Proteins from Polyacrylamide Gels to Nitrocellulose Sheets: Procedure and Some Applications
- Cluster analysis and display of genome-wide expression patterns
- Improved Tools for Biological Sequence Comparison
- Genomic Sequencing